ECMO is a highly specialised life-support technology used when a patient's heart or lungs can no longer function effectively on their own, providing critical support while the body recovers. Through ECMOASIA 2026, FMRI provided a platform for healthcare professionals to exchange knowledge, share clinical insights and explore the latest advancements in life-saving care.

A key highlight of the conference was the Institute's pioneering ECMO Retrieval Programme, which has successfully completed more than 150 domestic and international ECMO retrievals over the past two years. This includes complex, high-risk patient transfers from locations such as Phuket, Thailand, demonstrating Fortis's ability to deliver advanced critical care beyond geographical boundaries and ensure patients receive specialised treatment when every second counts.

The conference also showcased several remarkable patient recovery stories, highlighting the life-saving impact of ECMO in managing severe cardiac and respiratory conditions. These cases demonstrated how multidisciplinary expertise, advanced technology and timely intervention can help patients overcome critical health challenges and return to their families and communities.

In addition to scientific sessions and clinical case discussions, ECMOASIA 2026 featured dedicated learning opportunities for perfusionists and nursing teams, reinforcing the importance of continuous education and collaboration in advancing standards of care.

By bringing together experts from across the region, FMRI continues to strengthen clinical capabilities, foster innovation and raise awareness of advanced life-support technologies. As part of the IHH Healthcare network, Fortis Healthcare is helping to advance critical care excellence, demonstrating how collaboration and shared expertise can create meaningful outcomes for patients across our markets.